Ani pharmaceuticals announces the fda approval and launch of estradiol gel, 0.06%

Princeton, n.j., oct. 25, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that following final approval from the u.s. food and drug administration (fda) for its abbreviated new drug application (anda), the company launched estradiol gel, 0.06%. ani's estradiol gel, 0.06% is the generic version of the reference listed drug (rld) estrogel® gel, 0.06%.
ANIP Ratings Summary
ANIP Quant Ranking